These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2068176

  • 1. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
    Schilling FH, Oberrauch W, Schanz F, Treuner J.
    Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
    [No Abstract] [Full Text] [Related]

  • 2. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T, Nishi M, Shimada M, Nakadate H, Hatae Y, Naito H, Hanai J, Kawai T, Takasugi N.
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract] [Full Text] [Related]

  • 3. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
    Woods WG, Tuchman M, Lemieux B.
    Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
    [No Abstract] [Full Text] [Related]

  • 4. History and current status of neuroblastoma screening in Japan.
    Takeda T.
    Med Pediatr Oncol; 1989; 17(5):361-3. PubMed ID: 2796850
    [No Abstract] [Full Text] [Related]

  • 5. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
    Mathieu P, Philip T, Greffe J, Montegue A, Lacroix C.
    Clin Chim Acta; 1993 Nov 15; 220(2):229-32. PubMed ID: 8111967
    [No Abstract] [Full Text] [Related]

  • 6. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1986 Dec 15; 16(4):351-5. PubMed ID: 3795531
    [Abstract] [Full Text] [Related]

  • 7. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG.
    Pediatrics; 1990 Nov 15; 86(5):765-73. PubMed ID: 2152340
    [Abstract] [Full Text] [Related]

  • 8. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
    Lamedica G, Falcone R, De Bernardi B, Canini S.
    Minerva Pediatr; 1978 Jan 31; 30(2):137-46. PubMed ID: 642879
    [No Abstract] [Full Text] [Related]

  • 9. Neuroblastoma: the case for screening infants in North America.
    Woods WG, Tuchman M.
    Pediatrics; 1987 Jun 31; 79(6):869-73. PubMed ID: 3588142
    [Abstract] [Full Text] [Related]

  • 10. [Rapid determination of 4-hydroxy-3-methoxymandelic (vanilmandelic) acid and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid in urine by liquid chromatography with electrochemical detection].
    Satokata I, Asami T, Otsuka T, Sakai K.
    Rinsho Byori; 1986 Jul 31; 34(7):817-22. PubMed ID: 3761638
    [No Abstract] [Full Text] [Related]

  • 11. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR, Gregory D, Bernstein M, Clow CL, Weisdorf T, Dougherty GE, Auray-Blais C, Giguère R, Lemieux B, Laberge C.
    CMAJ; 1987 May 01; 136(9):952-6. PubMed ID: 3105859
    [Abstract] [Full Text] [Related]

  • 12. Screening for neuroblastoma (NB) in North America: the Quebec Project.
    Woods WG, Lemieux B, Leclerc JM, Bernstein ML, Brisson L, Brossard J, Brodeur GM, Look AT, Robison LL, Shuster JJ.
    Prog Clin Biol Res; 1994 May 01; 385():377-82. PubMed ID: 7972234
    [No Abstract] [Full Text] [Related]

  • 13. [Paracetamol interference with vanilmandelic and homovanillic acid quantification by the Bio-Rad HPLC kit].
    Drouard-Troalen L, Assicott MJ, Bonnay MM.
    Ann Biol Clin (Paris); 2002 May 01; 60(5):626-7. PubMed ID: 12405118
    [No Abstract] [Full Text] [Related]

  • 14. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T.
    Jpn J Clin Oncol; 1990 Sep 01; 20(3):268-70. PubMed ID: 2255102
    [Abstract] [Full Text] [Related]

  • 15. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Sep 01; 17(3):221-8. PubMed ID: 3669365
    [Abstract] [Full Text] [Related]

  • 16. Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
    Auray-Blais C, Giguère R, Lemieux B.
    Med Pediatr Oncol; 1989 Sep 01; 17(5):364-7. PubMed ID: 2796851
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-performance liquid chromatography: applications in a children's hospital.
    Soldin SJ.
    Adv Chromatogr; 1982 Sep 01; 20():139-66. PubMed ID: 6293278
    [No Abstract] [Full Text] [Related]

  • 20. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A.
    Gan To Kagaku Ryoho; 1990 Dec 01; 17(12):2319-26. PubMed ID: 2260868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.